Cedarlake Capital is a leading investment management firm with strategic focus on China.
Business Model:
Revenue: $0
Employees: 0-0
Address: Nanjing West Road
City: Shanghai
State: shanghai municipality
Zip: -
Country: CN
Cedarlake Capital is a leading investment management firm with strategic focus on China-related and cross-border investments and aspires to create synergies and alliance among global major industries, economies and capital markets. Cedarlake Capital was founded by Mr. Yi Bao, a top deal maker with more than 20 years of experience and track record in investment banking and private equity investments and former Chief Executive Officer of Morgan Stanley Huaxin Securities, Morgan Stanley&s;s securities platform in China. Cedarlake manages capital for renowned institutional investors, corporations and family offices and currently has a professional investment team with diverse backgrounds, outstanding track record and extensive experience in focused industries as well as deal execution.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2022 | MAXIEYE | Series C | - |
2/2022 | Inceptio Technology | Series B | 0 |
11/2021 | Spacety | Venture Round | - |
3/2021 | Iluvatar CoreX | Series C | 0 |
9/2020 | LandSpace | Series C | 0 |
7/2022 | SiEngine technology | Series A | 0 |
8/2022 | Listenai | Seed Round | - |
1/2022 | SiBionics | Series C | 0 |
6/2019 | Novena Global Healthcare Group | Private Equity Round | 0 |
6/2021 | Robosen | Series B | - |
7/2022 | SiEngine technology | Series A | 0 |
2/2022 | Inceptio Technology | Series B | 0 |
1/2022 | SiBionics | Series C | 0 |
11/2021 | Spacety | Venture Round | - |
6/2021 | Robosen | Series B | - |
3/2021 | Iluvatar CoreX | Series C | 0 |
9/2020 | LandSpace | Series C | 0 |
6/2019 | Novena Global Healthcare Group | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|